EchoGo Amyloidosis 1.0
EchoGo Amyloidosis 1.0 is a medical device (FDA Class II; FDA product code SDJ, Adjunctive Cardiac Amyloidosis Status Indicator) made by Ultromics, Ltd., cleared under FDA 510(k) K240860 on 15 Nov 2024 and listed in FDA GUDID since 17 Dec 2024 (UDI-DI 05060634690065), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05060634690065 | Date17 Dec 2024 | StatusListed |
| United States | FDA 510(k)SESE | NumberK240860 | Date15 Nov 2024 | StatusActive |
Official records
- AccessGUDID record 05060634690065
- FDA 510(k) database K240860
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- Labelled as not made with natural rubber latex
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K240860 decided 15 Nov 2024 Active
- FDA GUDID UDI-DI 05060634690065 listed 17 Dec 2024 Listed
Timeline
- Cleared FDA 510(k) K240860
- Listed FDA GUDID 05060634690065
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- EchoGo
- Generic name
- Radiology DICOM image processing application software
- Model / reference
- Amyloidosis 1.0
- Primary DI / UDI-DI
- 05060634690065
- 510(k) Number
- FDA product code
- SDJ
- GMDN term
- Radiology DICOM image processing application software
- Device class
- Class II
- Regulation number
- 870.2200
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Ultrasound imaging system application software.